サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1455680

プレシジョンオンコロジー市場：製品タイプ別、適応症タイプ別、最終用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024年～2032年

Precision Oncology Market, By Product Type, By Indication Type, By End Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 323 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.53円
プレシジョンオンコロジー市場：製品タイプ別、適応症タイプ別、最終用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024年～2032年
出版日: 2024年03月04日
発行: AnalystView Market Insights
ページ情報: 英文 323 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

プレシジョンオンコロジー市場規模は2023年に695億8,467万米ドルとなり、2024年から2032年にかけてCAGR 11.2％で拡大

プレシジョンオンコロジー市場-市場力学

技術進歩が市場需要を促進

市場成長の主な促進要因には、技術的進歩、効果的な臨床結果をもたらす診断製品に対する需要の高まり、それによって治療副作用を最小限に抑え、薬剤耐性を防止することなどが挙げられます。同様に、研究活動の拡大、乳がんの早期発見、患者の全体的な予後は、プレシジョンオンコロジーの需要を強化する構えです。COVID-19の大流行は、世界の社会的遠ざけ策と閉鎖により、プレシジョンオンコロジー市場に影響を与えました。さらに、パンデミックの初期段階では臨床試験研究が一時的に中止されました。しかし、パンデミック後、病院や診療所では、治療とともにプレシジョンオンコロジー分析のための患者流入が減少しています。プレシジョンオンコロジーによる診断と治療の遅れは、がん患者のケアに大きな影響を与えています。

プレシジョンオンコロジー市場-主な洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024-2032年）に約11.2％のCAGRで毎年成長すると予測されています。

製品タイプ別では、治療が2023年に最大の市場シェアを示すと予測されています。

適応症別では、2023年には乳がんが主要タイプに

地域別では、北米が2023年に収益を生み出す主要市場となっています。

プレシジョンオンコロジー市場-セグメンテーション分析：

プレシジョンオンコロジーの世界市場は、製品タイプ、適応症タイプ、最終用途、地域に基づいてセグメント化されます。

市場は製品タイプに基づいて診断と治療の2つに分類されます。2023年には、腫瘍診断治療の承認件数の増加や、がんの成長を促進する特定のタンパク質や変異に合わせた治療薬のユニークな特性などの要因によって、治療分野が市場リーダーに浮上しました。プレシジョンオンコロジーに基づく治療は、個々の患者のがんのDNA指紋に基づき、患者に特化したがん治療を提供します。

同市場は、適応症タイプによって、乳がん、大腸がん、子宮頸がん、肺がん、前立腺がん、その他の6つのカテゴリーに分類されます。2023年には、乳がんが最大の市場シェアを占めました。これは、乳がん検診、診断への注目の高まり、外科手術や放射線技術の進歩に起因します。さらに、研究努力の拡大、乳がんの早期発見、患者の予後改善が、プレシジョンオンコロジーのような新しい手法の開発を促進すると予想されます。さらに、DNA配列決定のための先端技術の出現は、乳がん患者の治療を急速に進歩させています。

プレシジョンオンコロジー市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

プレシジョンオンコロジー市場-競合情勢：

マーケットプレースでは、プレシジョンオンコロジーを専門とする企業が、診断ツール、分子プロファイリング技術、標的療法の革新に注力し、がん治療の成果を最適化しています。これらの企業は、さまざまながん種に関連するバイオマーカーや遺伝子変異を特定し、より正確な診断や治療法の選択を可能にすることを目的とした研究開発にリソースを割いています。さらに、これらの企業は医療プロバイダーに包括的なゲノムプロファイリングサービスを提供し、患者の腫瘍の分子的特徴に基づいて十分な情報に基づいた治療法の決定を行えるようにしています。さらに、マーケティングイニシアチブは、治療効果を高め、副作用を最小限に抑え、最終的に患者の転帰を改善するプレシジョンオンコロジーの利点について、腫瘍医、医療提供者、患者の認識を高めようとしています。プレシジョンオンコロジー分野の市場参入企業は、市場での存在感を高めるため、契約、新製品の発売、事業拡大など、さまざまな革新的戦略に取り組んでいます。

目次

第1章 プレシジョンオンコロジー市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 プレシジョンオンコロジーの主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 プレシジョンオンコロジー業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 プレシジョンオンコロジー市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 プレシジョンオンコロジー市場情勢

  • プレシジョンオンコロジー市場シェア分析、2023年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 プレシジョンオンコロジー市場-製品タイプ別

  • 概要
    • 製品タイプ別のセグメントシェア分析
    • 診断
    • 治療

第8章 プレシジョンオンコロジー市場-適応症タイプ別

  • 概要
    • 適応症タイプ別のセグメントシェア分析
    • 乳がん
    • 結腸直腸がん
    • 子宮頸がん
    • 前立腺がん
    • 肺がん
    • その他

第9章 プレシジョンオンコロジー市場-最終用途別

  • 概要
    • 最終用途別のセグメントシェア分析
    • 病院・診断研究所
    • 製薬・イオテクノロジー企業
    • 医療データ企業

第10章 プレシジョンオンコロジー市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東とアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- プレシジョンオンコロジー業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Invitae Corporation
    • Qiagen NV
    • Illumina, Inc.
    • Laboratory Corporation Of America Holding
    • Exact Sciences Corporation
    • Rain Oncology Inc.
    • Strata Oncology, Inc.
    • Xilis, Inc.
    • Variantyx, Inc.
    • Bioserve
    • Relay Therapeutics
    • Acrivon Therapeutics
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Precision Oncology Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Precision Oncology Market, by Product Type 2019-2032 (USD Million)
  • TABLE Precision Oncology Market: Indication Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication Type
  • TABLE Global Precision Oncology Market, by Indication Type 2019-2032 (USD Million)
  • TABLE Precision Oncology Market: End-Use Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-Use
  • TABLE Global Precision Oncology Market, by End-Use 2019-2032 (USD Million)
  • TABLE Precision Oncology Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Precision Oncology Market, by Region 2019-2032 (USD Million)
  • TABLE North America Precision Oncology Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Precision Oncology Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Precision Oncology Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE North America Precision Oncology Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Europe Precision Oncology Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Precision Oncology Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Precision Oncology Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Europe Precision Oncology Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Asia Pacific Precision Oncology Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Precision Oncology Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Precision Oncology Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Precision Oncology Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Latin America Precision Oncology Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Precision Oncology Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Precision Oncology Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Latin America Precision Oncology Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Precision Oncology Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Precision Oncology Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Precision Oncology Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Precision Oncology Market, by End-Use, 2019-2032 (USD Million)

List of Figures

  • FIGURE Precision Oncology Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product Type segment market share analysis, 2023 & 2032
  • FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indication Type segment market share analysis, 2023 & 2032
  • FIGURE Indication Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End-Use segment market share analysis, 2023 & 2032
  • FIGURE End-Use segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Precision Oncology Market share and leading players, 2023
  • FIGURE Europe Precision Oncology Market share and leading players, 2023
  • FIGURE Asia Pacific Precision Oncology Market share and leading players, 2023
  • FIGURE Latin America Precision Oncology Market share and leading players, 2023
  • FIGURE Middle East and Africa Precision Oncology Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Precision Oncology Market share analysis by country, 2023
  • FIGURE Germany Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Precision Oncology Market share analysis by country, 2023
  • FIGURE India Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Precision Oncology Market share analysis by country, 2023
  • FIGURE Brazil Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Precision Oncology Market share analysis by country, 2023
  • FIGURE Saudi Arabia Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Precision Oncology Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV2343

REPORT HIGHLIGHT

Precision Oncology Market size was valued at USD 69,584.67 Million in 2023, expanding at a CAGR of 11.2% from 2024 to 2032.

Precision oncology, also referred to as personalized or targeted cancer therapy, represents a tailored approach to cancer treatment, wherein medical interventions such as medications and treatment plans are customized to match the individual characteristics of each patient and their specific cancer subtype. This method considers various factors including the tumor's genetic makeup, molecular profile, and the patient's overall health, aiming to pinpoint the most effective treatment options with minimal side effects.

Precision Oncology Market- Market Dynamics

Technological advancements to propel market demand

Key drivers of market growth include technological advancements, a growing demand for diagnostic products delivering effective clinical results, thereby minimizing therapeutic side effects and preventing drug resistance. Similarly, expanding research activities, early detection of breast cancer, and overall patient prognosis are poised to bolster the demand for precision oncology. The COVID-19 pandemic has impacted the precision oncology market due to social distancing measures and lockdowns worldwide. Additionally, clinical trial studies were temporarily halted during the initial phase of the pandemic. However, post-pandemic, hospitals and clinics have experienced a decline in patient flow for precision oncology analysis along with therapeutic treatment. Delayed diagnosis and treatment using precision oncology have significantly affected cancer patient care.

Precision Oncology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.2% over the forecast period (2024-2032)

Based on Product Type segmentation, therapeutics was predicted to show maximum market share in the year 2023

Based on Indication Type segmentation, breast cancer was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Precision Oncology Market- Segmentation Analysis:

The Global Precision Oncology Market is segmented on the basis of Product Type, Indication Type, End Use, and Region.

The market is divided into two categories based on Product Type: diagnostics and therapeutics. In 2023, the therapeutics segment emerged as the market leader, propelled by factors such as the increasing amount of approvals for tumor-agnostic treatments and the unique characteristics of therapeutics tailored to specific proteins or mutations driving cancer growth. Precision oncology-based treatments offer patient-specific cancer treatment based on the DNA fingerprint of individually patient's cancer.

The market is divided into six categories based on Indication Type: breast cancer, colorectal cancer, cervical cancer, lung cancer, prostate cancer, and others. In 2023, breast cancer held the largest market share, attributed to the growing focus on breast cancer screening, diagnosis, and advancements in surgical and radiation techniques. Additionally, expanding research endeavors, early detection of breast cancer, and improved patient prognosis are expected to drive the development of novel methods like precision oncology. Furthermore, the advent of advanced technologies for DNA sequencing has rapidly advanced the treatment of breast cancer patients.

Precision Oncology Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Precision Oncology Market- Competitive Landscape:

In the marketplace, companies specializing in precision oncology concentrate on innovating diagnostic tools, molecular profiling technologies, and targeted therapies to optimize cancer treatment outcomes. They allocate resources to research and development endeavors aimed at identifying biomarkers and genetic mutations associated with different cancer types, enabling more accurate diagnosis and treatment selection. Additionally, these companies may provide comprehensive genomic profiling services to healthcare providers, empowering them to make informed treatment decisions based on the molecular characteristics of the patient's tumor. Moreover, marketing initiatives seek to raise awareness among oncologists, healthcare providers, and patients regarding the benefits of precision oncology in enhancing treatment efficacy, minimizing adverse effects, and ultimately improving patient outcomes. Market players in the precision oncology sector are engaging in various innovative strategies such as agreements, new product launches, and expansions to bolster their market presence.

Recent Developments:

In December 2021, ConcertAI, LLC, along with LabCorp declared a collaboration aimed at enhancing precision oncology research. These companies are collaborating to launch clinical studies that will alleviate the burden on physician practices and improve patient retention, thereby ensuring equitable access to research as a care option and driving patient recruitment.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PRECISION ONCOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Thermo Fisher Scientific Inc.

Invitae Corporation

Qiagen N.V.

Illumina, Inc.

Laboratory Corporation Of America Holding

Exact Sciences Corporation

Rain Oncology Inc.

Strata Oncology, Inc.

Xilis, Inc.

Variantyx, Inc.

Bioserve

Relay Therapeutics

Acrivon Therapeutics

Others

GLOBAL PRECISION ONCOLOGY MARKET, BY PRODUCT TYPE - MARKET ANALYSIS, 2019 - 2032

  • Diagnostics
  • Therapeutics

GLOBAL PRECISION ONCOLOGY MARKET, BY INDICATION TYPE- MARKET ANALYSIS, 2019 - 2032

  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Prostate Cancer
  • Lung Cancer
  • Others

GLOBAL PRECISION ONCOLOGY MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Healthcare Data Companies

GLOBAL PRECISION ONCOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Precision Oncology Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Precision Oncology Market Snippet by Product Type
    • 2.1.2.Precision Oncology Market Snippet by Indication Type
    • 2.1.3.Precision Oncology Market Snippet by End-Use
    • 2.1.4.Precision Oncology Market Snippet by Country
    • 2.1.5.Precision Oncology Market Snippet by Region
  • 2.2.Competitive Insights

3.Precision Oncology Key Market Trends

  • 3.1.Precision Oncology Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Precision Oncology Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Precision Oncology Market Opportunities
  • 3.4.Precision Oncology Market Future Trends

4.Precision Oncology Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Precision Oncology Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Precision Oncology Market Landscape

  • 6.1.Precision Oncology Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Precision Oncology Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Diagnostics
    • 7.1.3.Therapeutics

8.Precision Oncology Market - By Indication Type

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Indication Type, 2023 & 2032 (%)
    • 8.1.2.Breast Cancer
    • 8.1.3.Colorectal Cancer
    • 8.1.4.Cervical Cancer
    • 8.1.5.Prostate Cancer
    • 8.1.6.Lung Cancer
    • 8.1.7.Others

9.Precision Oncology Market - By End-Use

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By End-Use, 2023 & 2032 (%)
    • 9.1.2.Hospitals & Diagnostic Laboratories
    • 9.1.3.Pharmaceutical & Biotechnology Companies
    • 9.1.4.Healthcare Data Companies

10.Precision Oncology Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Precision Oncology Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Precision Oncology Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Precision Oncology Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Precision Oncology Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Precision Oncology Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Precision Oncology Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Thermo Fisher Scientific Inc.
    • 11.2.2.Invitae Corporation
    • 11.2.3.Qiagen N.V.
    • 11.2.4.Illumina, Inc.
    • 11.2.5.Laboratory Corporation Of America Holding
    • 11.2.6.Exact Sciences Corporation
    • 11.2.7.Rain Oncology Inc.
    • 11.2.8.Strata Oncology, Inc.
    • 11.2.9.Xilis, Inc.
    • 11.2.10.Variantyx, Inc.
    • 11.2.11.Bioserve
    • 11.2.12.Relay Therapeutics
    • 11.2.13.Acrivon Therapeutics
    • 11.2.14.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us